NEVVI Medicare utilization intelligence

← back

BORRA, RENUKAM.D. NPI 1386686558 Clinician

Hematology-Oncology · ODESSA, TX

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 40 years since medical school (class of 1986, self-reported to CMS)
Location ODESSA, TX · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 67 codes billed · 77,450 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
TEXAS ONCOLOGY PA
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2008-02

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9267 Injection, paclitaxel, 1 mg
J1756 Injection, iron sucrose, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J1437 Injection, ferric derisomaltose, 10 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J2469 Injection, palonosetron hcl, 25 mcg
J0640 Injection, leucovorin calcium, per 50 mg
80053 Blood test, comprehensive group of blood chemicals
J9190 Injection, fluorouracil, 500 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J3475 Injection, magnesium sulfate, per 500 mg
96413 Administration of chemotherapy into vein, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96375 Injection of additional new drug or substance into vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J9045 Injection, carboplatin, 50 mg
83735 Magnesium level
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
J3489 Injection, zoledronic acid, 1 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
83615 Lactate dehydrogenase (enzyme) level
96415 Administration of chemotherapy into vein, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
96361 Infusion into a vein for hydration, each additional hour
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96372 Injection of drug or substance under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J3490 Unclassified drugs
J7030 Infusion, normal saline solution , 1000 cc
80048 Blood test, basic group of blood chemicals (calcium, total)
85055 Reticulated (young) platelet measurement
96523 Irrigation of implanted venous access drug delivery device
85046 Red blood count automated, with additional calculations
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
71260 Ct scan of chest with contrast
84100 Phosphate level
74177 Ct scan of abdomen and pelvis with contrast
82378 Carcinoembryonic antigen (cea) protein level
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
82565 Blood creatinine level
84520 Urea nitrogen level to assess kidney function, quantitative
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
84153 Psa (prostate specific antigen) measurement, total
82270 Stool analysis for blood to screen for colon tumors
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
74176 Ct scan of abdomen and pelvis without contrast
96374 Injection of drug or substance into vein
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96360 Infusion into a vein for hydration, 31-60 minutes
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
71250 Ct scan of chest without contrast
99195 Drawing of blood for a medical problem

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.